Latest Articles
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Aussie tradie dies in a freak accident - News.com.au
Aussie tradie dies in a freak accident News.com.au
Published: June 2, 2025, 11 p.m.
Haley Pullos’ Latest Post Has Fans Begging For Her General Hospital Return - Soap Hub
Haley Pullos’ Latest Post Has Fans Begging For Her General Hospital Return Soap Hub
Published: June 2, 2025, 7:49 p.m.
Genmab (GMAB) Announces Promising Rina-S Data from Endometrial C - GuruFocus
Genmab (GMAB) Announces Promising Rina-S Data from Endometrial C GuruFocus
Published: June 2, 2025, 7:20 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) - GuruFocus
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) GuruFocus
Published: June 2, 2025, 7:05 p.m.
OPINION - I’ve passed out, been hospitalised and still done my job — Bella Hadid is right, working on your period should be illegal - MSN
OPINION - I’ve passed out, been hospitalised and still done my job — Bella Hadid is right, working on your period should be illegal MSN
Published: June 2, 2025, 6:50 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer - Medical Xpress
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer Medical Xpress
Published: June 2, 2025, 6:20 p.m.
Link copied to clipboard!